Evidence map›Paper›PMID 17276798›Full record

GuidelineAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2007

KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease.

KDOQI

7 registry-linked trialsAbstract readPractice Guideline
PubMed Publisher
In one paragraph

Guideline in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 7 registered trials, which are not on this map. Cited by 681 papers, 14 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
681citing papers in PubMed, 14 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01524705 phase4completedstarted 2012, after this paper: background citation

FLAT-SUGAR: FLuctuATion Reduction With inSULin and Glp-1 Added togetheR

Ran2012Enrolled102Registered outcomes4Posted comparisons3ConditionsType 2 DiabetesArmsexenatide, Insulin glargine, Metformin, Prandial insulin
PMID 19092145PMID 27208320PMID 9224218PMID 18765395PMID 18539917PMID 18539916PMID 18299315PMID 18198229PMID 17332893PMID 18779236PMID 10773760PMID 10880413other papers from this trial
Open the trial in the graph
NCT01067963 naterminatednot on this mapstarted 2009, after this paper: background citation

Self-management of Type 2 Diabetes and Chronic Kidney Disease

TypeinterventionalSponsorUniversity of Colorado, DenverRan2009 to 2012Enrolled80ConditionsDiabetes Mellitus, Type 2, Renal Insufficiency, ChronicArmsComputer assisted education and motivational interviewing., Group talks/social chat
NCT01978951 nacompletednot on this mapstarted 2011, after this paper: background citation

Effectiveness of Integrated Care on Delaying Chronic Kidney Disease Progression in Rural Communities of Thailand (ESCORT Study)

TypeinterventionalSponsorBhumirajanagarindra Kidney Institute, ThailandRan2011 to 2013Enrolled443ConditionsChronic Kidney DiseaseArmsIntegrated Chronic Kidney Disease care, Conventional CKD care
NCT02194790 nacompletednot on this mapstarted 2012, after this paper: background citation

Effect of Integrated CKD Care Program in Early Diabetic Nephropathy in Primary Health Care Setting.

TypeinterventionalSponsorBhumirajanagarindra Kidney Institute, ThailandRan2012 to 2013Enrolled238ConditionsChronic Kidney Disease, Diabetic NephropathyArmsCommunity-based Integrated CKD Care
NCT02690883 phase4completednot on this mapstarted 2016, after this paper: background citation

Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy: a 24- Week Study

TypeinterventionalSponsorNanfang Hospital, Southern Medical UniversityRan2016 to 2019Enrolled92ConditionsDiabetic NephropathiesArmsExenatide, Lispro
NCT05021705 completednot on this mapstarted 2016, after this paper: background citation

Non Diabetic Causes of Chronic Kidney Disease in Type 2 Diabetic Patients

Typeobservational_patient_registrySponsorAssiut UniversityRan2016 to 2020Enrolled60ConditionsDiabetic Kidney Disease
NCT05691985 unknown statusnot on this mapstarted 2024, after this paper: background citation

Fibrinogen to Albumin Ratio (FAR) as a Risk Factor for Type 2 Diabetic Nephropathy(DN)

Typeobservational_patient_registrySponsorAssiut UniversityRan2024 to 2025Enrolled50ConditionsCKD, Type 2 Diabetes
3 · Its place in the literature

Who cites it

681 citing papers in PubMed, 14 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Education programmes for people with chronic kidney disease and diabetes.The Cochrane database of systematic reviews · 2024
    Pooled it
  5. Antihypertensive treatment for kidney transplant recipients.The Cochrane database of systematic reviews · 2024
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Protein restriction for diabetic kidney disease.The Cochrane database of systematic reviews · 2023
    Pooled it
  9. Pooled it
  10. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2022
    Guideline
  11. Pooled it
  12. Guideline
  13. Efficacy and safety ofFrontiers in pharmacology · 2022
    Pooled it
  14. Pooled it
  15. Trial
  16. Trial
  17. Trial
  18. Article
  19. Observational
  20. Article

621 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

KDOQI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Chronic DiseaseDiabetes ComplicationsDiabetes MellitusHumansKidney Diseases

Identifiers

PMID17276798

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

and 1 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.